Follicle Stimulating Hormone Market Report 2024 (Global Edition)

Global Follicle Stimulating Hormone Market Report 2024 Market Size Split by Type (Recombinant FSH, Urinary FSH), by End Use (Hospitals, Fertility Clinics, Cryobanks), by Application (Infertility Treat...

Follicle Stimulating Hormone Market Report Description

We have various report editions of Follicle Stimulating Hormone Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Follicle Stimulating Hormone Market Insights Video

Competitive Landscape of the Follicle Stimulating Hormone Market

The competitive landscape of the follicle stimulating hormone market is characterized by a range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established electronics manufacturers, specialized follicle stimulating hormone companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

August 2022: Myovant Sciences and Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved Myfembree. It is once-a-day therapy for the management of moderate to severe pain associated with endometriosis in pre-menopausal women, with a treatment duration of up to 24 months. (Source: https://www.pfizer.com/news/press-release/press-release-detail/myovant-sciences-and-pfizer-receive-us-fda-approval#:~:text=MYFEMBREE%20(relugolix%2C%20estradiol%2C%20and,of%20up%20to%2024%20months.)

Top Companies Market Share in Follicle Stimulating Hormone Industry: (In no particular order of Rank)

• Merck Serono (Germany)
• MSD (US.)
• IBSA (Switzerland)
• Ferring (Switzerland)
• Livzon (China)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Follicle Stimulating Hormone Market

Which Region Dominates the Follicle Stimulating Hormone Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue due to the region's increasing awareness and diagnosis of fertility issues, coupled with advancements in reproductive technology. Enhanced fertility treatments, rising demand for assisted reproductive technologies (ART), and the growing prevalence of disorders affecting fertility are also contributing to market growth in the region.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the follicle stimulating hormone market due to the region's increasing fertility awareness, rising incidences of hormonal disorders, and advancements in reproductive technologies. Growing healthcare infrastructure and the expansion of fertility clinics also contribute to the market's growth as more people seek effective treatments for infertility and related conditions.

The current report Scope analyzes Follicle Stimulating Hormone Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Follicle Stimulating Hormone

According to Cognitive Market Research, the global follicle stimulating hormone market size was estimated at USD 1415.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 566.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 1.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the follicle stimulating hormone market with a market size of USD 446.64 million in 2024 and is projected to grow at a CAGR of 1.5% during the forecast period. The nation's increasing awareness about reproductive health.
• The Canada follicle stimulating hormone market had a market share of USD 67.93 million in 2024 and is projected to grow at a CAGR of 2.5% during the forecast period. Canada's increased need for follicle stimulating hormone technology.
• The Mexico follicle stimulating hormone market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD 51.51 million in 2024.

Europe Follicle Stimulating Hormone

According to Cognitive Market Research, the global follicle stimulating hormone market size was estimated at USD 1415.2 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 424.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.0% from 2024 to 2031.

• The United Kingdom follicle stimulating hormone market had a market share of USD 71.33 million in 2024 and is projected to grow at a CAGR of 7.2% during the forecast period. In the UK, follicle stimulating hormone sales witness an upswing due to the nation's rising demand for this technology.
• The France follicle stimulating hormone market is projected to witness growth at a CAGR of 1.2% during the forecast period, with a market size of USD 39.06 million in 2024.
• According to Cognitive Market Research, the German follicle stimulating hormone market size was valued at USD 84.06 million in 2024 and is projected to grow at a CAGR of 2.2% during the forecast period. In Germany, follicle stimulating hormone surged due to the presence of major market players.
• The Italy follicle stimulating hormone market is projected to witness growth at a CAGR of 1.4% during the forecast period, with a market size of USD 36.51 million in 2024.
• The Russia follicle stimulating hormone market is projected to witness growth at a CAGR of 1.0% during the forecast period, with a market size of USD 65.81 million in 2024.
• The Spain follicle stimulating hormone market is projected to witness growth at a CAGR of 1.1% during the forecast period with a market size of USD 34.81 million in 2024
• The Luxembourg follicle stimulating hormone market is projected to witness growth at a CAGR of 2.1% during the forecast period, with a market size of USD 13.16 million in 2024.
• The Portugal follicle stimulating hormone market is projected to witness growth at a CAGR of 1.8% during the forecast period, with a market size of USD 8.92 million in 2024.
• The Greece follicle stimulating hormone market is projected to witness growth at a CAGR of 2.3% during the forecast period, with a market size of USD 5.09 million in 2024.
• Rest of Europe's follicle stimulating hormone market is projected to witness growth at a CAGR of 0.7% during the forecast period, with a market size of USD 65.81 million in 2024.

Asia Pacific Follicle Stimulating Hormone

According to Cognitive Market Research, the global follicle stimulating hormone market size was estimated at USD 1415.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 325.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.

• According to Cognitive Market Research, the China follicle stimulating hormone market size was valued at USD 146.47 million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. Follicle stimulating hormone surged in China due to the adoption of various technologies.
• The Japan follicle stimulating hormone market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 44.92 million in 2024.
• The India follicle stimulating hormone market had a market share of USD 39.06 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. India's supportive initiatives taken by the government.
• The South Korean follicle stimulating hormone market is projected to witness growth at a CAGR of 4.6% during the forecast period, with a market size of USD 32.55 million in 2024.
• The Australian follicle stimulating hormone market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 16.93 million in 2024.
• The South East Asia follicle stimulating hormone market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 22.46 million in 2024.
• The Rest of Asia Pacific follicle stimulating hormone market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 23.11 million in 2024.

South America Follicle Stimulating Hormone

According to Cognitive Market Research, the global follicle stimulating hormone market size was estimated at USD 1415.2 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 70.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.9% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil follicle stimulating hormone market size was valued at USD 30.29 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. Follicle stimulating hormone flourished in Brazil due to the rising consumer preference for convenience foods.
• Argentina's follicle stimulating hormone market had a market share of USD 11.89 million in 2024 and is projected to grow at a CAGR of 3.8% during the forecast period. Argentina's technological advancements augment the demand.
• Colombia follicle stimulating hormone market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 6.30 million in 2024.
• Peru follicle stimulating hormone market is projected to witness growth at a CAGR of 3.1% during the forecast period, with a market size of USD 5.80 million in 2024.
• Chile follicle stimulating hormone market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 5.09 million in 2024.
• The Rest of Latin America's follicle stimulating hormone market is projected to witness growth at a CAGR of 2.0% during the forecast period, with a market size of USD 11.39 million in 2024.

Middle East and Africa Follicle Stimulating Hormone

According to Cognitive Market Research, the global follicle stimulating hormone market size was estimated at USD 1415.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 28.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031.

• The GCC Countries follicle stimulating hormone market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 12.11 million in 2024. Follicle stimulating hormone sales flourish due to the presence of major market players.
• The Egypt follicle stimulating hormone market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 2.97 million in 2024.
• The South Africa follicle stimulating hormone market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 4.47 million in 2024. Follicle stimulating hormone sales flourished in South Africa due to technological advancements, increasing demand, and regulatory support.
• The Turkey follicle stimulating hormone market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 2.43 million in 2024.
• The Nigeria follicle stimulating hormone market is projected to witness growth at a CAGR of 2.3% during the forecast period, with a market size of USD 2.97 million in 2024.
• The Rest of MEA follicle stimulating hormone market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD 3.34 million in 2024.

Follicle Stimulating Hormone Market Analysis

Follicle Stimulating Hormone Market Type Segment Analysis

According to Cognitive Market Research, the dominant category is recombinant FSH due to the increasing use of recombinant FSH in fertility treatments and assisted reproductive technologies. Recombinant FSH offers higher purity and efficacy compared to traditional forms, improving treatment outcomes for conditions such as polycystic ovary syndrome and male hypogonadism, thus boosting market demand.

The fastest-growing category in the follicle stimulating hormone market is urinary FSH due to increasing prevalence of fertility disorders and advancements in reproductive technologies. Urinary FSH is crucial for fertility treatments and assisted reproductive technologies, making it a key component in addressing infertility issues and enhancing reproductive health solutions.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Follicle Stimulating Hormone Industry. Request a Free Sample PDF!

Follicle Stimulating Hormone Market End-Use Segment Analysis

According to Cognitive Market Research, the dominant category is fertility clinics due to their role in ovarian stimulation during assisted reproductive technologies. As more couples seek fertility treatments, the increased use of FSH to enhance egg production and improve treatment outcomes boosts the market for this hormone, supporting the growth of fertility clinics and related services.

The fastest-growing category in the follicle stimulating hormone market is hospitals due to increasing demand for personalized medicine and advanced reproductive technologies drives the adoption of follicle stimulating hormone therapies, fostering improved patient outcomes and contributing to the expansion of specialized hospital services in this field.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Follicle Stimulating Hormone Application Segment Analysis

Follicle Stimulating Hormone Market Application Segment Analysis

According to Cognitive Market Research, the dominant category is infertility treatment due to the increasing prevalence of reproductive disorders and rising awareness about advanced fertility treatments. FSH is crucial for stimulating ovarian function and promoting egg production, which supports effective treatment protocols and boosts demand for fertility medications and related healthcare solutions.

The fastest-growing category in the follicle stimulating hormone market is assisted reproductive technology as assisted reproductive technology procedures like IVF and IUI gain popularity, the demand for follicle stimulating hormone to stimulate ovarian follicles and improve fertility outcomes rises. This growth in assisted reproductive technology drives the need for advanced follicle stimulating hormone treatments and therapies.

• Infertility Treatment
• Assisted Reproductive Technology

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion